Natural resistance mechanisms may play a role in protection against chemical carcinogenesis - PubMed (original) (raw)
- PMID: 6984356
- PMCID: PMC11039255
- DOI: 10.1007/BF00205312
Natural resistance mechanisms may play a role in protection against chemical carcinogenesis
P Brodt et al. Cancer Immunol Immunother. 1982.
Abstract
Mice deprived of B lymphocytes by the chronic administration of anti-IgM antibodies have been shown to possess a heightened natural resistance (NR) to micro-organisms, to parental bone marrow, and to natural killer (NK)-sensitive tumors in vitro and in vivo. Experiments described in this communication indicate that the latent period of primary tumors induced by the injection of methylcholanthrene (MC) is also prolonged in these mice. This observation suggests that NR mechanisms may provide protection against primary chemically induced tumors.
Similar articles
- Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor.
Brodt P, Gordon J. Brodt P, et al. J Immunol. 1978 Jul;121(1):359-62. J Immunol. 1978. PMID: 307580 - [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice].
Viksler VKh, Iaroslavtseva OA, Lavroskiĭ VA. Viksler VKh, et al. Eksp Onkol. 1986;8(6):36-40. Eksp Onkol. 1986. PMID: 3803287 Russian. - Suppressive effects of 3-methylcholanthrene on the in vitro antitumor activity of naturally cytotoxic cells.
Lill PH, Gangemi JD. Lill PH, et al. J Toxicol Environ Health. 1986;17(4):347-56. doi: 10.1080/15287398609530829. J Toxicol Environ Health. 1986. PMID: 3959116 - Do natural killer cells engage in regulated reactions against self to ensure homeostasis?
Cudkowicz G, Hochman PS. Cudkowicz G, et al. Immunol Rev. 1979;44:13-41. doi: 10.1111/j.1600-065x.1979.tb00266.x. Immunol Rev. 1979. PMID: 367948 Review.
Cited by
- Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues.
de Jonge H, Iamele L, Maggi M, Pessino G, Scotti C. de Jonge H, et al. Cancers (Basel). 2021 Feb 15;13(4):813. doi: 10.3390/cancers13040813. Cancers (Basel). 2021. PMID: 33672007 Free PMC article. Review. - The tumor-promoting effects of the adaptive immune system: a cause of hyperprogressive disease in cancer?
Marcucci F, Rumio C. Marcucci F, et al. Cell Mol Life Sci. 2021 Feb;78(3):853-865. doi: 10.1007/s00018-020-03606-8. Epub 2020 Sep 17. Cell Mol Life Sci. 2021. PMID: 32940721 Free PMC article. Review. - Cancer systems immunology.
Reticker-Flynn NE, Engleman EG. Reticker-Flynn NE, et al. Elife. 2020 Jul 13;9:e53839. doi: 10.7554/eLife.53839. Elife. 2020. PMID: 32657757 Free PMC article. Review. - B cell regulation in cancer and anti-tumor immunity.
Sarvaria A, Madrigal JA, Saudemont A. Sarvaria A, et al. Cell Mol Immunol. 2017 Aug;14(8):662-674. doi: 10.1038/cmi.2017.35. Epub 2017 Jun 19. Cell Mol Immunol. 2017. PMID: 28626234 Free PMC article. Review. - Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models.
Guy TV, Terry AM, Bolton HA, Hancock DG, Shklovskaya E, Fazekas de St. Groth B. Guy TV, et al. Cancer Immunol Immunother. 2016 Aug;65(8):885-96. doi: 10.1007/s00262-016-1848-z. Epub 2016 May 24. Cancer Immunol Immunother. 2016. PMID: 27222052 Free PMC article. Review.
References
- Baldwin RW. Immunological aspects of chemical carcinogenesis. Adv Cancer Res. 1973;18:1. - PubMed
- Balner H, Dersjant H. Neonatal thymectomy and tumor induction with methylcholanthrene in mice. J Natl Cancer Inst. 1966;36:513. - PubMed
- Brodt P, Gordon J. Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor. J Immunol. 1978;121:359. - PubMed
- Brodt P, Gordon J. Anti-tumor immunity in B lymphocyte-deprived mice. II. In vitro studies. Cell Immunol. 1981;65:20. - PubMed
- Brodt P, Kongshavn P, Vargas F, Gordon J. Increased natural host resistance mechanisms in B lymphocyte-deprived mice. J Reticuloendothel Soc. 1981;30:283. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources